Skip to main navigation Skip to search Skip to main content

Mutations in RARS Cause Hypomyelination

  • N.I. Wolf
  • , G.S. Salomons
  • , R.J. Rodenburg
  • , P.J.W. Pouwels
  • , J.H. Schieving
  • , T.G.J. Derks
  • , J.M. Fock
  • , P. Rump
  • , D.M. van Beek
  • , M.S. van der Knaap
  • , Q. Waisfisz

    Research output: Contribution to JournalArticleAcademicpeer-review

    Abstract

    Hypomyelinating disorders of the central nervous system are still a diagnostic challenge, as many patients remain without genetic diagnosis. Using magnetic resonance imaging (MRI) pattern recognition and whole exome sequencing, we could ascertain compound heterozygous mutations in RARS in 4 patients with hypomyelination. Clinical features included severe spasticity and nystagmus. RARS encodes the cytoplasmic arginyl-tRNA synthetase, an enzyme essential for RNA translation. This protein is among the subunits of the multisynthetase complex, which emerges as a key player in myelination. Ann Neurol 2014;76:134-139 © 2014 American Neurological Association.
    Original languageEnglish
    Pages (from-to)134-139
    JournalAnnals of Neurology
    Volume76
    Issue number1
    DOIs
    Publication statusPublished - 2014

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Mutations in RARS Cause Hypomyelination'. Together they form a unique fingerprint.

    Cite this